ACTA NEUROPATHOLOGICA

Scope & Guideline

Pioneering Insights into Neurological Diseases

Introduction

Welcome to your portal for understanding ACTA NEUROPATHOLOGICA, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0001-6322
PublisherSPRINGER
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1961 to 2024
AbbreviationACTA NEUROPATHOL / Acta Neuropathol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

ACTA NEUROPATHOLOGICA focuses on the intricate relationship between neuropathology and neurodegenerative diseases, providing a platform for innovative research that enhances our understanding of brain disorders at both molecular and cellular levels.
  1. Neurodegenerative Disease Mechanisms:
    The journal emphasizes the study of underlying mechanisms of neurodegenerative diseases such as Alzheimer's, ALS, and other tauopathies, exploring aspects like protein misfolding, neuroinflammation, and cellular death pathways.
  2. Tumor Biology and Neuropathology:
    ACTA NEUROPATHOLOGICA publishes research on brain tumors, particularly focusing on molecular and genetic profiling, which aids in understanding tumor behavior, classification, and potential therapeutic targets.
  3. Molecular and Cellular Pathology:
    The journal integrates studies that investigate molecular and cellular changes in various brain disorders, including the roles of specific proteins, genetic mutations, and epigenetic modifications.
  4. Biomarkers and Diagnostic Innovations:
    Research on biomarkers for early detection and diagnosis of neurodegenerative diseases and brain tumors is a key focus, aiming to improve patient outcomes through innovative diagnostic approaches.
  5. Neuroinflammation and Immune Response:
    The journal covers the role of neuroinflammation and immune responses in both neurodegenerative diseases and brain tumors, highlighting how these processes contribute to pathology and potential therapeutic strategies.
Recent publications in ACTA NEUROPATHOLOGICA indicate a shift towards specific, innovative themes that reflect the latest advancements in neuroscience and pathology, demonstrating the journal's responsiveness to emerging trends.
  1. Role of TDP-43 and Tau Pathology:
    There is an increasing focus on TDP-43 and tau proteins in various neurodegenerative diseases, particularly their roles in disease progression and as potential therapeutic targets.
  2. Integration of Multi-Omics Approaches:
    Emerging studies utilize multi-omics approaches (genomics, proteomics, metabolomics) to provide comprehensive insights into disease mechanisms, indicating a trend towards holistic understanding of brain disorders.
  3. Neuroinflammation and Immune Mechanisms:
    Research exploring the contributions of neuroinflammation and the immune system to neurodegenerative diseases is gaining traction, reflecting a growing recognition of these factors in disease pathology.
  4. Biomarkers and Precision Medicine:
    There is a notable increase in studies aimed at identifying biomarkers for diagnosis and prognosis, aligning with the broader movement towards precision medicine in neurology.
  5. Genetic and Epigenetic Influences:
    Studies focusing on genetic and epigenetic factors influencing neurodegenerative diseases and brain tumors are on the rise, underscoring the importance of understanding individual variability in disease manifestation.

Declining or Waning

While ACTA NEUROPATHOLOGICA has consistently published influential research, certain themes appear to be declining in prominence as the field evolves and new areas of interest emerge.
  1. Traditional Histopathology Techniques:
    There is a noticeable reduction in the publication of papers solely focused on traditional histopathological techniques, as researchers increasingly turn to advanced molecular and genetic approaches for deeper insights into neuropathology.
  2. General Neuropathological Descriptions:
    Papers that provide broad, descriptive accounts of neuropathological findings without specific molecular or genetic context are becoming less frequent, reflecting a shift towards more detailed mechanistic studies.
  3. Non-specific Neurodegenerative Disease Studies:
    Research that does not focus on specific neurodegenerative mechanisms or lacks a clear connection to molecular pathways is waning, as the journal favors studies with targeted hypotheses and translational relevance.

Similar Journals

NEUROSCIENCE RESEARCH

Illuminating New Paths in Neuroscience Research
Publisher: ELSEVIER IRELAND LTDISSN: 0168-0102Frequency: 12 issues/year

NEUROSCIENCE RESEARCH, published by Elsevier Ireland Ltd, is a leading journal in the field of neuroscience, with a notable reputation for disseminating high-quality research that spans a variety of topics within the discipline. With an ISSN of 0168-0102 and an E-ISSN of 1872-8111, this journal serves as a vital platform for both established researchers and emerging voices in the field. Ranking in the Q2 quartile in both Medicine and Neuroscience categories, it has been recognized as a reliable source of innovative findings since its inception in 1984, with continuous publication through 2024. Although it does not currently offer Open Access options, the journal is indexed in Scopus, holding a significant position at Rank #48/113 in General Neuroscience, reflecting its contribution to advancing the understanding of neural mechanisms across various contexts. With its address anchored in Ireland, NEUROSCIENCE RESEARCH plays an essential role in bridging scientific inquiry and practical applications, making it an indispensable resource for researchers, professionals, and students dedicated to the burgeoning field of neuroscience.

FOLIA NEUROPATHOLOGICA

Connecting researchers to vital neuropathological findings.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1641-4640Frequency: 4 issues/year

FOLIA NEUROPATHOLOGICA is a distinguished Open Access journal specializing in the fields of Neurology and Pathology, published by the reputable TERMEDIA PUBLISHING HOUSE LTD. With an ISSN of 1641-4640 and E-ISSN 1509-572X, this journal has been a vital resource for the dissemination of high-quality research since its inception in 1994. Covering a broad spectrum of topics within neuropathology, the journal emphasizes clinical findings and forensic implications, making it an essential platform for healthcare professionals, researchers, and students alike. With impressive impact factors positioning it in the Q3 category for both Neurology (clinical) and Pathology and Forensic Medicine, FOLIA NEUROPATHOLOGICA occupies a significant place among its peers, ranked within the 36th to 46th percentiles on Scopus. Scholars can benefit from the Open Access model implemented since 2005, ensuring wide accessibility and distribution of critical research outputs aimed at advancing both clinical practices and academic knowledge. Based in Poland, at KLEEBERGA 2, POZNAN 61-615, this journal continues to shape the discourse in neuropathology and related fields.

MOLECULAR NEUROBIOLOGY

Advancing Knowledge in Cellular and Molecular Neuroscience
Publisher: SPRINGERISSN: 0893-7648Frequency: 12 issues/year

Welcome to Molecular Neurobiology, the premier journal dedicated to the exploration of the molecular mechanisms underlying nervous system function and pathophysiology. Published by Springer, this journal provides an essential platform for disseminating high-quality research in the rapidly evolving fields of Cellular and Molecular Neuroscience and Neurology, boasting an impressive impact factor that reflects its esteemed position within the academic community. With its ranking in the Q1 and Q2 quartiles for various neuroscience categories, Molecular Neurobiology stands at the forefront of groundbreaking discoveries, showcasing innovative studies that bridge basic science and clinical application. Researchers and professionals are invited to contribute to its rich portfolio, which spans from fundamental insights into cellular processes to advanced therapeutic strategies. Although Molecular Neurobiology does not operate as an Open Access journal, its influential body of work remains accessible through institutional and personal subscriptions. As we converge from 1987 to 2024, we continue to aim for excellence, seeking to catalyze progress in understanding neurological diseases and enhance the scientific dialogue within the neuroscience community.

NEUROPATHOLOGY

Innovating Insights into Neurological Health
Publisher: WILEYISSN: 0919-6544Frequency: 6 issues/year

NEUROPATHOLOGY, an esteemed journal published by WILEY, is a pivotal platform in the fields of medicine and neurology, focusing on the intricate relationship between pathology and neurological disorders. Established in 1993 and continually evolving until 2024, the journal holds a notable presence within the academic community, as evidenced by its current Q2 ranking in several categories including Medicine (Miscellaneous), Neurology (Clinical), and Pathology and Forensic Medicine. With a Scopus ranking placing it within the top 30% of its field, NEUROPATHOLOGY serves as a vital resource for researchers, healthcare professionals, and students dedicated to advancing their knowledge of neuropathological processes. Although not an Open Access journal, it ensures accessibility to cutting-edge research and insights that shape contemporary understanding and clinical practice. Its robust impact factor underscores the journal's critical role in disseminating innovative findings within the realms of neurology and pathology, making it an essential read for those at the forefront of medical research.

CELL

Advancing the frontiers of cellular discovery.
Publisher: CELL PRESSISSN: 0092-8674Frequency: 26 issues/year

CELL is a premier academic journal in the field of Biochemistry, Genetics, and Molecular Biology, published by CELL PRESS. Founded in 1974, this esteemed journal has steadfastly contributed to advancing our understanding of cellular processes and organisms, making it integral for researchers and practitioners alike. With an impressive impact factor that places it in the Q1 category of its field, CELL ranks #1 out of 221 in general biochemistry and genetics, achieving a remarkable 99th percentile in Scopus rankings. Though it is not currently an open-access publication, the journal regularly disseminates high-quality research that impacts the scientific community significantly. Researchers, students, and professionals seeking to stay at the forefront of innovative discoveries and methodologies in molecular biology will find CELL an invaluable resource through its comprehensive articles and reviews.

BRAIN PATHOLOGY

Advancing the Frontiers of Brain Research
Publisher: WILEYISSN: 1015-6305Frequency: 6 issues/year

BRAIN PATHOLOGY, published by WILEY, is a leading journal in the fields of neurology, neuroscience, and pathology, recognized for its rigorous peer-review process and high-impact research contributions. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories, BRAIN PATHOLOGY maintains a prominent status, with a Scopus ranking placing it among the top 10% of journals in its fields. Since its inception in 1990, the journal has served as a crucial platform for researchers and clinicians alike, disseminating groundbreaking findings that advance our understanding of brain diseases and injuries. Through its dedication to publishing high-quality, innovative research, BRAIN PATHOLOGY plays a vital role in shaping the future of brain pathology research. While it does not currently offer open access, articles can be accessed through institutional subscriptions. Researchers, professionals, and students are encouraged to contribute to and engage with this esteemed publication to foster knowledge and collaboration within this dynamic field.

Annual Review of Neuroscience

Advancing the Frontiers of Neuroscience Knowledge
Publisher: ANNUAL REVIEWSISSN: 0147-006XFrequency: 1 issue/year

The Annual Review of Neuroscience, published by Annual Reviews, is a premier journal that has been at the forefront of neuroscience research since its inception in 1978. With an ISSN of 0147-006X and E-ISSN 1545-4126, this leading academic journal boasts a remarkable impact factor, placing it in the prestigious Q1 category in Neuroscience (miscellaneous), with an impressive Scopus ranking of 4 out of 113 and a stellar 96th percentile in general neuroscience. Focused on publishing comprehensive and authoritative review articles, the Annual Review of Neuroscience aims to synthesize and critically evaluate the latest advances in the field, making it an indispensable resource for researchers, professionals, and students alike. While it does not offer open access, the insights and discoveries highlighted in its issues are crucial for those dedicated to understanding the complexities of the nervous system and driving forward innovative research. With a commitment to excellence and a forward-looking perspective, this journal continues to shape and influence the future of neuroscience.

Purinergic Signalling

Exploring the Frontiers of Purinergic Research
Publisher: SPRINGERISSN: 1573-9538Frequency: 4 issues/year

Purinergic Signalling, published by Springer, is a pivotal academic journal dedicated to the exploration of purinergic signaling pathways and their implications in various biological processes. Since its inception in 2004, the journal has made significant contributions to the fields of Cell Biology, Cellular and Molecular Neuroscience, and Molecular Biology, consistently ranking in the Q3 category in recent assessments. With a strong focus on the molecular mechanisms of purines and their roles in physiology and pathology, Purinergic Signalling serves as an essential resource for researchers and professionals seeking to understand the complexity of cellular communication. Although it does not offer open access, the journal ensures a broad dissemination of high-quality research findings, making it a vital tool for academic advancement in the fields of neuroscience and molecular biology. Its commitment to scholarly excellence is reflected in its Scopus rankings, where it is competitively positioned within its categories. As we approach its 20th anniversary in 2024, Purinergic Signalling continues to inspire and inform cutting-edge research in the dynamic landscape of life sciences.

Translational Neurodegeneration

Empowering Global Collaboration in Neuroscience
Publisher: BMCISSN: 2047-9158Frequency: 1 issue/year

Translational Neurodegeneration, an esteemed journal in the field of neuroscience, is published by BMC and has been an open access platform since 2012, delivering high-quality research from its base in the United Kingdom. With an impressive impact factor reflecting its significant contributions, this journal focuses on critical advancements in cellular and molecular neuroscience, cognitive neuroscience, and clinical neurology, boasting a Q1 ranking across all these categories as of 2023. Researchers and professionals benefit from its extensive reach, characterized by exceptional Scopus rankings that place it in the top percentile of its field. The journal serves as a vital resource for academics and healthcare practitioners alike, aiming to bridge the gap between laboratory discoveries and clinical applications, thereby enhancing understanding and treatment of neurodegenerative diseases. With its commitment to open access, Translational Neurodegeneration ensures that its published research is accessible to a global audience, promoting collaboration and knowledge exchange within the scientific community.

FASEB BioAdvances

Exploring Breakthroughs in Biological Research
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.